Fig. 2
From: Mir-338-3p targeting THBS1 attenuates glioma progression by inhibiting the PI3K/Akt pathway
miR-338-3p overexpression inhibited glioma tumor growth in vivo. Mice were injected with 2 × 107 agomiR-338-3p/NC-transfected U251 cells. The mice were observed every 4 days. On day 28, the mice were sacrificed, and their tumors were collected. (A) Representative pictures of tumors in each group. (B, C) The volume (B) and weight (C) of the tumors were measured in each group. **P < 0.001 vs. agomiR-NC